Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,287 results for ""Cobicistat""

Your Filters

Publisher : wiley-blackwell
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study.

  • Authors : Vos CF; Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.; Hemminga WL

Subjects: Ketamine*/Ketamine*/Ketamine*/administration & dosage ; Ketamine*/Ketamine*/Ketamine*/pharmacokinetics ; Biological Availability*

  • Source: Pharmacotherapy [Pharmacotherapy] 2024 Jun; Vol. 44 (6), pp. 480-484. Date of Electronic Publication: 2024 May 31.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Report

Cobicistat: A case of mislabelled drug-drug interaction risk?

  • Authors : Burger DM; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Calmy A

Subjects: Anti-HIV Agents*/Anti-HIV Agents*/Anti-HIV Agents*/pharmacology ; Cobicistat*/Cobicistat*/Cobicistat*/pharmacology ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2020 May; Vol. 86 (5), pp. 834-836. Date of Electronic Publication: 2020 Mar 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.

  • Authors : Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel and University of Basel, Basel, Switzerland.; Decosterd L

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacokinetics ; Cobicistat/Cobicistat/Cobicistat/*blood ; Cobicistat/Cobicistat/Cobicistat/*pharmacokinetics

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2017 Dec; Vol. 83 (12), pp. 2835-2838. Date of Electronic Publication: 2017 May 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Reduced exposure to darunavir and cobicistat in HIV‐1‐infected pregnant women receiving a darunavir/cobicistat‐based regimen.

Subjects: COMBINATION drug therapy; COMPARATIVE studies; GESTATIONAL age

  • Source: HIV Medicine. May2019, Vol. 20 Issue 5, p337-343. 7p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy

Subjects: PACLITAXEL; PANCREATIC duct; CYTOCHROME P-450 CYP3A

  • Source: CTS: Clinical & Translational Science; Dec2023, Vol. 16 Issue 12, p2483-2493, 11p

Record details

Read More Add to Saved list
×
Academic Journal

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.

Subjects: CHOLESTEROL; HIGH density lipoproteins; HIV-positive persons

  • Source: HIV Medicine. Nov2017, Vol. 18 Issue 10, p782-786. 5p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cobicistat as a Pharmacoenhancer in Pregnancy and Postpartum: Progress to Date and Next Steps.

Subjects: COMBINATION drug therapy; GLYCOPROTEINS; PEPTIDESUNITED States. Food & Drug Administration

  • Source: Journal of Clinical Pharmacology; Jun2019, Vol. 59 Issue 6, p779-783, 5p

Record details

Read More Add to Saved list
×
Academic Journal

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort.

Subjects: MENTAL illness risk factors; RALTEGRAVIR; ABACAVIR

  • Source: HIV Medicine. Mar2019, Vol. 20 Issue 3, p237-247. 11p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase‐Positive Non‐Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat.

Subjects: NON-small-cell lung carcinoma; CRIZOTINIB; ANAPLASTIC lymphoma kinase

  • Source: CTS: Clinical & Translational Science; Mar2021, Vol. 14 Issue 2, p487-491, 5p

Record details

Read More Add to Saved list
×
Academic Journal

Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection.

Subjects: RITONAVIR; ANTIRETROVIRAL agents; PHARMACOKINETICS

  • Source: Pharmacotherapy; Oct2013, Vol. 33 Issue 10, p1107-1116, 10p

Record details

Read More Add to Saved list
×
  • 1-10 of  1,287 results for ""Cobicistat""